期刊文献+

甲酰肽受体1在膀胱癌细胞中的表达及其分析

Expression and Functional Analysis of Formyl Peptide Receptor 1 in Bladder Cancer Cells
下载PDF
导出
摘要 目的探究甲酰肽受体1在膀胱癌细胞中的表达及其激活后的作用。方法利用实时荧光定量PCR方法和蛋白免疫印迹法检测正常膀胱上皮细胞和T24和pumc-91细胞甲酰肽受体1mRNA和蛋白的表达量,用甲酰肽受体1的激活剂f MLP激活甲酰肽受体1后,实时荧光定量PCR方法检测IL-8 mRNA表达量。结果基因水平上,甲酰肽受体1在两株膀胱癌细胞和正常的膀胱上皮细胞中均表达,与正常的膀胱上皮细胞相比T24和pumc-91细胞均低表达;蛋白水平上,FPR1在两株膀胱癌细胞中也均表达,与正常膀胱上皮相比T24和pumc-91细胞均高表达。f MLP激活FPR1后,T24和pumc-91膀胱癌细胞IL-8mRNA的表达量增加。结论 FPR1在膀胱癌细胞中高表达并且调控T24和pumc-91细胞IL-8mRNA的分泌,可能与膀胱癌的发生发展相关。 Objective This study was to explore the differential expression and functional role of Formyl Peptide Receptor1 in bladder cancer. Methods The expressions of FPR1 in T24 and pumc-91 cells were measured by qRT-PCR and Western Blot. T24 and pumc-91 cells were cultured with fMLP for 48 h,and then IL-8 mRNA was measured by qRT-PCR. Results FPR1 gene had low expression,while FPR1 protein was over expressed in T24 and pumc-91 bladder cancer cells compared with SV-HUC-1 normal bladder epithelial cells. FPR1 activation improved the expression of IL-8 mRNA. Conclusion FPR1 is highly expressed in bladder cancer cells and regulates the secretion of IL-8 mRNA in T24 and pumc-91 cells,which may be related with the development and progression of bladder cancer.
作者 姜雪 张曼 JIANG Xue;ZHANG Man(Department of Clinical Laboratory, Capital Medical University, Beijing Shijitan Hospital, Department of Clinical Laboratory, Peking University Ninth School of Clinical Medicine, Beijing Key Laboratory of Urinary Cellular and Molecular Diagnostics, Beijing 100038 ,China)
出处 《标记免疫分析与临床》 CAS 2018年第4期565-568,583,共5页 Labeled Immunoassays and Clinical Medicine
基金 北京市自然科学基金(编号:7172106) 北京市医管局首届登峰人才计划(编号:DFL20150701)
关键词 甲酰肽受体1 膀胱癌 FMLP 白细胞介素8 Formyl peptide receptor 1 Bladder cancer fMLP IL-8
  • 相关文献

参考文献2

二级参考文献42

  • 1李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
  • 2中华人民共和国卫生部.全国第三次死因回顾抽样调查报告[M].北京:中国协和医科大学出版社,2008.10.
  • 3卫生部全国肿瘤防治研究办公室.中国恶性肿瘤死亡调查研究[M].北京:人民卫生出版社,1979.
  • 4Deng X Y, Ueda H, Su S B, et al. A synthetic peptide derived from human immunodeficiency virus type 1 gp120downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled rec
  • 5Bylund J, Karlsson A, Boulay F, et al. Lipopolysaccharideinduced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2-20), which activates formyl peptide receptor-like 1. Infect Immun, 2002,70(6): 2908~2914
  • 6Chen X, Mellon R D, Yang L, et al. Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants. Biochem Pharmacol, 2002,63:533~541
  • 7Mills J S, Miettinen H M, Cummings D, et al. Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phc and Met-Met-Trp-Leu-Leu. J Biol Chem, 2000, 275(50):39012~39017
  • 8Shen W P, Proost P, Li B Q, et al. Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines. Biochem Biophys Res Commun, 2000, 272:276~283
  • 9Le Y Y, Gong W H, Li B Q, et al. Utilization of two seventransmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activatio n. J Immunol, 1999, 163:6777
  • 10Su S B, Gao J L, Gong W H, et al. T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-proteincoupled formyl peptide receptors. J Immunol, 1999, 162:5924~5930

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部